Cheryl R. Blanchard - 09 Mar 2026 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
Director
Signature
/s/ Cheryl R. Blanchard
Issuer symbol
ANIK
Transactions as of
09 Mar 2026
Net transactions value
$0
Form type
4
Filing time
11 Mar 2026, 16:24:57 UTC
Previous filing
05 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Blanchard Cheryl R Director C/O ANIKA THERAPEUTICS, INC., 32 WIGGINS AVENUE, BEDFORD /s/ Cheryl R. Blanchard 11 Mar 2026 0001326530

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Options Exercise +20,001 +10% 217,321 09 Mar 2026 Direct F1
transaction ANIK Common Stock Tax liability -5,871 -2.7% $14.96* 211,450 09 Mar 2026 Direct F2
holding ANIK Common Stock 11,742 09 Mar 2026 Revocable Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIK Restricted Stock Unit Options Exercise -20,001 -100% $0.000000* 0 09 Mar 2026 Common Stock 20,001 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.
F2 Reflects an aggregate of 5,871 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2026.
F3 Consists of shares held by The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which the Reporting Person is a beneficiary and the sole trustee.
F4 On March 9, 2023, the Reporting Person was granted 60,004 RSUs vesting in three equal annual installments beginning on March 9, 2024. This transaction reflects the third and final vesting installment of such RSU award.